ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Congress Insists On No Downward Negotiations; NCI May Drop 2000 To 300 Grants In FY 1991

November 9, 1990

Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack

January 8, 1993

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010